Treatment-resistant depression refers to depression indicators that don’t respond to two or more types of antidepressant medication. Estimates recommend as much as 30% of men and women with major depression have treatment-resistant depression. investigated using ketamine as an adjuvant to intrapleural ropivacaine in patients undergoing thoracostomy. Ketamine presented significant quick https://fionaq900pft8.eedblog.com/profile